Please login to the form below

Not currently logged in

Samsung BioLogics

This page shows the latest Samsung BioLogics news and features for those working in and with pharma, biotech and healthcare.

Moderna’s COVID-19 vaccine offers high levels of protection for adolescents

Moderna’s COVID-19 vaccine offers high levels of protection for adolescents

Moderna and Samsung Biologics have signed a deal for large-scale, commercial fill-finish capabilities for mRNA-1273. ... distribution in the early second half of 2021," said John Rim, chief executive officer of Samsung Biologics.

Latest news

More from news
Approximately 3 fully matching, plus 6 partially matching documents found.

Latest Intelligence

  • Pharma deals during July 2012 Pharma deals during July 2012

    Two weeks prior to the announcement of the collaboration between Amgen and Watson, Biogen Idec and Samsung Biologics announced the establishment of a $300m joint venture to develop and commercialise biosimilars.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs


Add my company
OPEN Health

OPEN Health brings together deep scientific knowledge, global understanding, and broad specialist expertise to support our clients in improving health...

Latest intelligence

Robust Review: COVID19 Assessment
See how our client utilized Rapid Payer Response (RPR) to stay informed and gain continuous insights during the recent global pandemic (COVID19)...
Human behaviour - Sept 21
All change – how untangling human behaviour can encourage better health
Driving better patient outcomes through clear, achievable practical steps that are underpinned by transparent evidence...
Health literacy in the time of COVID-19
In a time when much of the media’s focus is on the ongoing COVID-19 pandemic and the differences in vaccination rates between various regions, countries, and socioeconomic groups, improving health...